Ascendis Pharma AS
(NAS:ASND)
$
127.67
-0.7225 (-0.56%)
Market Cap: 7.63 Bil
Enterprise Value: 8.09 Bil
PE Ratio: 0
PB Ratio: 0
GF Score: 73/100 
Ascendis Pharma A/S at Bank of America Healthcare Conference Transcript
May 12, 2022 / 05:40PM GMT
Release Date Price:
$80.01
(+2.47%)
Tazeen Ahmad
BofA Securities, Research Division - MD in Equity Research & Research Analyst
Good morning. Welcome back to the Bank of America Healthcare Conference. So I am Tazeen Ahmad. I'm one of the senior SMid biotech analysts here at the firm. It's my pleasure to have our next presenting company, Ascendis Pharma.
Sitting up here with me are 2 members from the management team. We have Jan Mikkelsen, who is, of course, President and CEO; as well as Scott Smith, who so is CFO. So gentlemen, good morning. Thanks for joining us.
Scott T. Smith;S;CFO
Ascendis Pharma A;Senior VP & Member of Executive Board
/- -
Thanks, Tazeen.
Jan Moller Mikkelsen;S;President;Tazeen Ahmad
Ascendis Pharma A;CEO, Member of Executive Board & Executive Director;BofA Securities, Research Division - MD in Equity Research & Research Analyst<
/- -
Thanks, Tazeen. We're happy to see you again face to face.
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers